Calculate the mass, volume, or concentration required for a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
E126853-5mg | 5mg | In stock | $112.90 | |
E126853-25mg | 25mg | In stock | $508.90 | |
E126853-100mg | 100mg | In stock | $1,830.90 | |
E126853-500mg | 500mg | In stock | $8,237.90 |
Selective ferrotopsis activator
Synonyms | ERASTIN|571203-78-6|2-[1-[4-[2-(4-chlorophenoxy)acetyl]-1-piperazinyl]ethyl]-3-(2-ethoxyphenyl)-4(3H)-Quinazolinone|2-(1-(4-(2-(4-chlorophenoxy)acetyl)piperazin-1-yl)ethyl)-3-(2-ethoxyphenyl)quinazolin-4(3H)-one|MFCD09837984|2-[1-[4-[2-(4-chlorophenoxy)ac |
---|---|
Specifications & Purity | ≥99% |
Storage Temp | Store at -20°C,Argon charged |
Shipped In | Dry ice |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
IUPAC Name | 2-[1-[4-[2-(4-chlorophenoxy)acetyl]piperazin-1-yl]ethyl]-3-(2-ethoxyphenyl)quinazolin-4-one |
---|---|
INCHI | InChI=1S/C30H31ClN4O4/c1-3-38-27-11-7-6-10-26(27)35-29(32-25-9-5-4-8-24(25)30(35)37)21(2)33-16-18-34(19-17-33)28(36)20-39-23-14-12-22(31)13-15-23/h4-15,21H,3,16-20H2,1-2H3 |
InChi Key | BKQFRNYHFIQEKN-UHFFFAOYSA-N |
Canonical SMILES | CCOC1=CC=CC=C1N2C(=O)C3=CC=CC=C3N=C2C(C)N4CCN(CC4)C(=O)COC5=CC=C(C=C5)Cl |
Isomeric SMILES | CCOC1=CC=CC=C1N2C(=O)C3=CC=CC=C3N=C2C(C)N4CCN(CC4)C(=O)COC5=CC=C(C=C5)Cl |
WGK Germany | 3 |
PubChem CID | 11214940 |
Molecular Weight | 547.04 |
Enter Lot Number to search for COA:
To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
Certificate of Analysis | Aug 10, 2023 | E126853 | |
Certificate of Analysis | Aug 10, 2023 | E126853 | |
Certificate of Analysis | Aug 10, 2023 | E126853 | |
Certificate of Analysis | Aug 10, 2023 | E126853 | |
Certificate of Analysis | Nov 22, 2022 | E126853 | |
Certificate of Analysis | Nov 22, 2022 | E126853 | |
Certificate of Analysis | Nov 22, 2022 | E126853 | |
Certificate of Analysis | Nov 22, 2022 | E126853 | |
Certificate of Analysis | May 19, 2022 | E126853 | |
Certificate of Analysis | May 19, 2022 | E126853 | |
Certificate of Analysis | May 19, 2022 | E126853 | |
Certificate of Analysis | May 19, 2022 | E126853 | |
Certificate of Analysis | Mar 24, 2022 | E126853 |
Solubility | 25°C: DMSO |
---|---|
Sensitivity | air & heat sensitive |
Pictogram(s) | GHS06 |
---|---|
Signal | Danger |
Hazard Statements | H301 |
Precautionary Statements | P321,P405,P501,P264,P270,P330,P301+P316 |
WGK Germany | 3 |
Starting at $241.90
1. Torii S et al.. (2016) An essential role for functional lysosomes in ferroptosis of cancer cells.. Biochem J, [PMID:26759376] |
2. Chen L et al.. (2021) Characterization of Interplay Between Autophagy and Ferroptosis and Their Synergistical Roles on Manipulating Immunological Tumor Microenvironment in Squamous Cell Carcinomas.. Front Immunol, 12 (739039). [PMID:35185859] |
3. Xie Y et al.. (2016) Ferroptosis: process and function.. Cell Death Differ, [PMID:26794443] |
4. Simamura E et al.. (2008) Mitochondrial voltage-dependent anion channels (VDACs) as novel pharmacological targets for anti-cancer agents.. J Bioenerg Biomembr, 40 (3): (213-7). [PMID:18704666] |
5. Haß C et al.. (2016) Sensitization of acute lymphoblastic leukemia cells for LCL161-induced cell death by targeting redox homeostasis.. Biochem Pharmacol, [PMID:26774450] |